This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Oliver Chow

Oliver S Chow, Thoracic Surgeon

NewYork-Presbyterian Queens
56-45 Main Street, Suite S376
Flushing, NY  11355
United States
You need to be logged in to see this email (login)
Surgeon - Cardiothoracic


Thoracic Surgeon
Assistant Professor of Clinical Cardiothoracic Surgery - Weill Cornell Medicine

Cardiothoracic Surgery Fellow - Beth Israel Deaconess Medical Center, Boston, MA
General Surgery Resident - Beth Israel Deaconess Medical Center, Boston, MA
Surgical Research Fellow - Memorial Sloan Kettering Cancer Center, New York, NY
General Surgery Resident - Rutgers - New Jersey Medical School, Newark, NJ

Other Interests

Selected publications

Chow OS, Kuk D, Keskin M, Smith JJ, Camacho N, Pelossof R, Chen CT, Chen Z, Avila K, Weiser MR, Berger MF, Patil S, Bergsland E, Garcia-Aguilar J. KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy. Ann Surg Oncol 2016 Mar 28 [Epub ahead of print]

Pelossof R*, Chow OS*, Fairchild L, Smith JJ, Setty M, Chen CT, Chen Z, Egawa F, Avila K, Leslie CS, Garcia-Aguilar J. Integrated Genomic Profiling Identifies MicroRNA-92a Regulation of IQGAP2 in Locally Advanced Rectal Cancer. Genes, Chromosomes & Cancer 2016; 55(4):311-21 *equal contributors

Garcia-Aguilar J, Chow OS, Smith DD, Marcet JE, Cataldo PA, Varma MG, Kumar AS, Oommen S, Coutsoftides T, Hunt SR, Stamos MJ, Ternent CA, Herzig DO, Fichera A, Polite BN, Dietz DW, Patil S, Avila K. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncology 2015; 16(8):957-66

Garcia-Aguilar J, Renfro LA, Chow OS, Shi Q, Carrero XW, Lynn PB, Thomas CR Jr, Chan E, Cataldo PA, Marcet JE, Medich DS, Johnson CS, Oommen SC, Wolff BG, Pigazzi A, McNevin SM, Pons RK, Bleday R. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncology 2015 Oct 13 [Epub ahead of print]

Smith JJ, Chow OS, Gollub MJ, Nash GM, Temple LK, Weiser MR, Guillem JG, Paty PB, Avila K, Garcia-Aguilar J; Rectal Cancer Consortium. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. BMC Cancer 2015;15(1):767

Chow OS, Huang JT, Sambol JT, Bolanowski PJ, Lovoulos CJ. Innominate artery injury from disseminated tuberculosis. Asian Cardiovasc Thorac Ann 2014 [Epub ahead of print]


Board Certifications

American Board of Surgery

American Board of Thoracic Surgery

Additional Educational Information

M.D. - Icahn School of Medicine at Mount Sinai, New York, NY
B.A. - Cornell University, Ithaca, NY
IB Graduate - Upper Canada College, Toronto, Canada

Practice Areas

  • Thoracic
  • Minimally Invasive
  • VATS
  • Thoracic
  • Lung
  • Esophagus
  • Mediastinum
  • Trachea and bronchi
  • Cancer